当前位置: X-MOL 学术Circulation › 论文详情
Short-Chain Fatty Acid Propionate Protects From Hypertensive Cardiovascular Damage
Circulation ( IF 23.054 ) Pub Date : 2018-12-04 , DOI: 10.1161/CIRCULATIONAHA.118.036652
Hendrik Bartolomaeus, András Balogh, Mina Yakoub, Susanne Homann, Lajos Markó, Sascha Höges, Dmitry Tsvetkov, Alexander Krannich, Sebastian Wundersitz, Ellen G. Avery, Nadine Haase, Kristin Kräker, Lydia Hering, Martina Maase, Kristina Kusche-Vihrog, Maria Grandoch, Jens Fielitz, Stefan Kempa, Maik Gollasch, Zhaxybay Zhumadilov, Samat Kozhakhmetov, Almagul Kushugulova, Kai-Uwe Eckardt, Ralf Dechend, Lars Christian Rump, Sofia K. Forslund, Dominik N. Müller, Johannes Stegbauer, Nicola Wilck

Background:Arterial hypertension and its organ sequelae show characteristics of T cell–mediated inflammatory diseases. Experimental anti-inflammatory therapies have been shown to ameliorate hypertensive end-organ damage. Recently, the CANTOS study (Canakinumab Antiinflammatory Thrombosis Outcome Study) targeting interleukin-1β demonstrated that anti-inflammatory therapy reduces cardiovascular risk. The gut microbiome plays a pivotal role in immune homeostasis and cardiovascular health. Short-chain fatty acids (SCFAs) are produced from dietary fiber by gut bacteria and affect host immune homeostasis. Here, we investigated effects of the SCFA propionate in 2 different mouse models of hypertensive cardiovascular damage.Methods:To investigate the effect of SCFAs on hypertensive cardiac damage and atherosclerosis, wild-type NMRI or apolipoprotein E knockout–deficient mice received propionate (200 mmol/L) or control in the drinking water. To induce hypertension, wild-type NMRI mice were infused with angiotensin II (1.44 mg·kg–1·d–1 subcutaneous) for 14 days. To accelerate the development of atherosclerosis, apolipoprotein E knockout mice were infused with angiotensin II (0.72 mg·kg–1·d–1 subcutaneous) for 28 days. Cardiac damage and atherosclerosis were assessed using histology, echocardiography, in vivo electrophysiology, immunofluorescence, and flow cytometry. Blood pressure was measured by radiotelemetry. Regulatory T cell depletion using PC61 antibody was used to examine the mode of action of propionate.Results:Propionate significantly attenuated cardiac hypertrophy, fibrosis, vascular dysfunction, and hypertension in both models. Susceptibility to cardiac ventricular arrhythmias was significantly reduced in propionate-treated angiotensin II–infused wild-type NMRI mice. Aortic atherosclerotic lesion area was significantly decreased in propionate-treated apolipoprotein E knockout–deficient mice. Systemic inflammation was mitigated by propionate treatment, quantified as a reduction in splenic effector memory T cell frequencies and splenic T helper 17 cells in both models, and a decrease in local cardiac immune cell infiltration in wild-type NMRI mice. Cardioprotective effects of propionate were abrogated in regulatory T cell–depleted angiotensin II–infused mice, suggesting the effect is regulatory T cell–dependent.Conclusions:Our data emphasize an immune-modulatory role of SCFAs and their importance for cardiovascular health. The data suggest that lifestyle modifications leading to augmented SCFA production could be a beneficial nonpharmacological preventive strategy for patients with hypertensive cardiovascular disease.
更新日期:2019-03-12

 

分享到
评论: 0
期刊列表
高分子化学
医师节
纳米研究精选
招聘实习生
中澳未来科学会议
China in Space
BMC Public Health
北大深研院会议广告
课题组网站
Springer Nature
Nature中文内容
深圳职业技术学院
内蒙古大学王春燕
Prof. David Leigh华东师范大学
北京大学化学学院席振峰
南京大学
试剂库存
X-MOL文献直达记录功能上线
天合科研
2017年中科院JCR分区化学大类列表
化合物查询
down
wechat
bug